Symbol
CRVS on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
8,609,091 shares
Security Ownership %
10%
Shares, Excluding Options vs Price
Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS)

27 Jan 2026 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,609,091 shares of Corvus Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (CRVS). This represents 10% ownership of the company. In their previous filing dated 14 May 2025, ORBIMED ADVISORS LLC had reported owning 9,785,423 shares, indicating a decrease of +12%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.